{"name":"Cell Therapy Ltd.","slug":"cell-therapy-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tendoncel","genericName":"Tendoncel","slug":"tendoncel","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Tendoncel","genericName":"Tendoncel","slug":"tendoncel","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPc1Q0ZENwUkozRU91dDVYV1pLSEN2b2w5VE80R1Y1MlFoZHJsX2FMSnc3WVZOZHlIamVYMTQxTlFqTDBvWl94dWdTd2xtckZJcE54Ml9oVXcyRTdqV01LeHJ3VDhveHdqLWtwSzB3MDNkZ1RwdjFmZDMwZDF4ekx2Ynl6YXFlejdlVUNlWDB6UHNVSHpfQU9wSmhTdG9LUG1ZenZTTQ?oc=5","date":"2026-02-24","type":"pipeline","source":"BioWorld News","summary":"Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies - BioWorld News","headline":"Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQSzV6aTFpUDZrYkhtNUFoOWpBYjRxRkxCOF9FTmNvQWpPX21Fb2N3dC1QSlc5U1RoalZ4aVBLQXdWSVZKZUpCVGlYblBPV1dBOWdtRl95S2g4dmRqeUtHNGRzSURSRFRKQVpvQmxseEh2Z0lRZmpWOE8wTGtMdEE4ajU1aDVMdkh2TzU4MGpZUGJvSjZ1cEhGb0pNSERDZnNaY0pteTN4aU93dk9NLU9Z?oc=5","date":"2026-02-19","type":"pipeline","source":"Bloomberg.com","summary":"Japan’s Regenerative Cell Therapy Push Faces Crucial Review - Bloomberg.com","headline":"Japan’s Regenerative Cell Therapy Push Faces Crucial Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQUDRBdG5ROWF3V01scDByZ3lkZzYyNUlKX3o4R2tveUNRTVhLbEhLVU10U05la0lnZWFnazdKRUJZa1RzMjlsYzI4STdqbTAzRF9tZndJUXh4U0FCRjZrdHhlTFQxZ2k3bEU2dTZad3FYYzczNDM2Z19XMi0xRTdzMW5zN1RDdG9YSVBPaWIyTzRVZmJGR3Y5V3VlTl9lV2lSOF9SOUhHeHlyT0t1ZGttUENmeUdyUl83cklJeThlM284dUhTMloxaU9td1FrYjNfVkVWeEVvMkdwSjJBcFFoWV9fU05tMjBXcGwyS3BjTnhIWVhCNFBfckxKNjlKQXRLVUxlWWpRdmFEUHFFb05IWTVwSnBvV1JZelE?oc=5","date":"2026-01-07","type":"pipeline","source":"Business Wire","summary":"RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta - Business Wire","headline":"RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxPZkxPY1pxYTlrRF9nMEdOTDYxcDl2RWE5UHRxT2p5eXN3NVBVRVVpVUtWU0VOakducF9EUmdzdXIxajc2MmMtSGZBc2N4SzMzLWc4NE0ydEwycFA1VnZpVkpVNkdjR3F3ZkNRVVB5N0JSVmtSQzZabmRGeFl5R3JSSFAxWGJtektuOWY4QmhQMUhDMUM1WFA1WHBtbnlLWEx3YjN0ODYyYjJoemZtbHY0YkExSHJsenotTXhlVU80U3RuS2hTang3RzNwLVZ2eUdSemdUTG1JU0JZdDEwN3FkYU9BSVNrN0t4UmRXUkVCMU10a1hBdjFZTnNCWHNRLUNaSkU4WDQ1UVU5OUU3RHhLX0dlU09YQ3dsNXZoLUE2UzVEd25rM28wNXd6T2pIWEdNaVZMeVlwZF9jaUpkVUlrU1lyMXFCck1jVm9laTJQVQ?oc=5","date":"2025-12-16","type":"deal","source":"Business Wire","summary":"RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge - Business Wire","headline":"RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxONUcyZkZtLVFSSWFpdGhncGlEYXF3OVZNV0lrMzB0M1dKNlhQUHFuLXZfT1V4NGdMSnV0UC1VektMVFA0SV8wQmd1LWxFTDZlZ2FlWlVHY3hYdjlEbEtIM3ctX2NqbHdkaTBpYnUwODdVTjNPR0xjeTFjTnZZejhVMHVnQ3JRcEoyS3lOSUtlcFBhRGc?oc=5","date":"2025-11-06","type":"pipeline","source":"Insightace Analytic","summary":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-28","type":"deal","source":"ET Pharma","summary":"MEDINET Japan, Stempeutics India ink deal for Stempeucel Cell Therapy for CLTI - ET Pharma","headline":"MEDINET Japan, Stempeutics India ink deal for Stempeucel Cell Therapy for CLTI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPQjJ2VUhMM1Q5LUpUZWtQbERDaUNmenM4b3htblk1Slk2eHdpRjVoNk5iWHZzZ2NBWkNlUi1SUFZacERUaHBRemU5cFdGSUk5b3JaeTFsYnM4VUxrd0ZoVFRpUEw1bE5VcjU5ZG9FUjc3dkNSZHNxTzNFR2VSR0xfQmNsbw?oc=5","date":"2025-10-07","type":"pipeline","source":"BioWorld News","summary":"Takeda ditches cell therapy business - BioWorld News","headline":"Takeda ditches cell therapy business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9LNXNoUzRvQ2lnVVNzcTFIcHlkeHpXbGpZandrSW5UODhjb0ZjS0lLSVVXOUJ4OGJWT2ZleEtacTF2YUFTcDFnR0dYUXVaNVNxVERaNHliMWEtMnBKbVFJU29uOHB3OG5IVTNvTmFjQjl1WXZvN1h0c2FpUHl5QUk?oc=5","date":"2025-09-23","type":"pipeline","source":"Global Growth Insights","summary":"Who Are the Global Leaders in CAR T-Cell Therapy? Top 10 Companies List - Global Growth Insights","headline":"Who Are the Global Leaders in CAR T-Cell Therapy? Top 10 Companies List","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNNGRUX0lXbFhZMjJkUnBoUmNZOEpxLW53QU1oY1NhZlRaM25PTWt0WHBYLUg0bjFuS2MtZUV1UlgwS0ZORWNFNzRmTTBoOXAzUFU3cmZpVk5XcC1VVjN6OTNwVm9qSWl0OGxVRE5XQnlGTkZ1bEtReGx3eDZTdU50cE1lVVZCVUFVajZtMllTZk44VTBhZzdnLTA0dGg5YzcyVGVzNmZncFVBYUI5em0wTk4tUW1fRUkxVF84bXFMX3Q5cEJjV2RIai11cHFobV90azlxVUJBWFcweWhUUlJoSi13dmlFQmtJVVZjOUtmSQ?oc=5","date":"2025-03-11","type":"regulatory","source":"CRISPR Medicine News","summary":"RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge - CRISPR Medicine News","headline":"RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNU2xkYXdKZzNRbzFqclZ4bTIxWlp6UEdwck5ia1h2Q3duZ2xqXzZqUjJBXzBvTkpxX3pQU3UtazY0cy1WOHNIVUc3d0FKbGozZHE2akx0V3ZhSDB0c0gwUkJ6NUFyX3FGRXh6OGx2M3c1UmZrTmYwUFc0YVc1dzRqdE9nbURnTjJ2MnZmWkNsQkUzTkp4QjA5dXVOLWtXc1pucnc5M1ZDODRzaHR0QUhmTTZIeElneFd3eUFwMThfYXBrNENiS2poSU5sbjZvc0h5bTdCTDJQV01fZ1VnTnlz?oc=5","date":"2020-09-29","type":"deal","source":"PR Newswire","summary":"CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd - PR Newswire","headline":"CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}